Terapia de medicina nuclear Ensayos clínicos Mayo Clinic
Terapia de medicina nuclear - Ensayos clínicos - Mayo Clinic
5 estudios en Terapia de medicina nuclear
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc.
5 estudios en Terapia de medicina nuclear
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc.
COVID-19 consejos información actualizada y opciones de vacunas
Infórmate sobre la COVID-19 y las vacunas contra esta enfermedad, y conoce las novedades para pacientes y visitantes de Mayo Clinic. Para navegación del sitio Para acceso a contenido Este contenido no tiene una versión en inglésEste contenido no tiene una versión en árabe Search Pida una consulta Para encontrar un doctor Para encontrar trabajo Para donar Acceso a su cuenta de paciente Español English العربية 简体中文 Twitter Facebook Pinterest YouTube Menú Departamentos y centros Centros y departamentos médicosTerapia de medicina nuclear
Ensayos clínicos
A continuación, se enumeran los ensayos clínicos actuales.5 estudios en Terapia de medicina nuclear
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc.
A Study to Develop and Validate Hybrid Molecular Imaging to Transform the Care of Hepatocellular Carcinoma Patients
Rochester, Minn. The primary purpose of this study is to evaluate diagnostic performance of 68Ga-PSMA-dual contrast (gadavist and gadoxetate) PET/MRI OR PET/CT for HCC using surgical histopathology (either resection, transplant or biopsy specimens) or LI-RADS categorization as gold standard.Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients with Tumor Induced Osteomalacia
Rochester, Minn. This study aims to identify cases of FGF23-mediated oncogenic osteoomalacia in which the underlying phosphaturic mesenchymal has not been found and perform 68Ga-DOTATATE PET in these patients to localize the tumor.A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients
Scottsdale/Phoenix, Ariz., Rochester, Minn., Jacksonville, Fla. The purpose of this study is to combine robust clinical data (e.g., prior chemotherapy or radiation exposure, cumulative Peptide Receptor Radionuclide Therapy (PRRT dose)) with genetic and clonal abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in PRRT-treated neuroendocrine tumor (NET) patients.A Study of Lutetium Lu 177 Dotatate Lutathera in Patients with Inoperable Progressive Meningioma after External Beam Radiation Therapy
Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate.Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET
Rochester, Minn. The purpose of this study is to determine if Lutathera in combination with long-acting octreotide prolongs PFS in GEP-NET patients with high proliferation rate tumors (G2 and G3), when given as a first line treatment compared to treatment with high dose (60 mg) long-acting octreotide. Somatostatin analog (SSA) naive patients are eligible, as well as patients previously treated with SSAs in the absence of progression. Conocimientos y categoríasInvestigación April 28, 2022 Comparte en: FacebookTwitter A continuación, se enumeran los ensayos clínicos actuales.5 estudios en Terapia de medicina nuclear
(solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc.